The Ethics of Predictive Health: How Early is Too Early to Act?
When Sofia’s genetic test results arrived, they contained a number that would change her life: an 87% likelihood of developing early-onset Alzheimer’s within the next twenty years. She was 38, a mother of two, and — at that moment — entirely healthy.
Her neurologist offered no treatment plan, because there was no disease to treat. What he offered instead was a choice: join a prevention study, change lifestyle factors, begin frequent scans. The science was certain enough to warn her, but not certain enough to cure her.
The Ethics of Predictive Health: How Early is Too Early to Act? Read More »